KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Intangibles (2016 - 2025)

AbbVie (ABBV) has disclosed Intangibles for 14 consecutive years, with $52.6 billion as the latest value for Q4 2025.

  • Quarterly Intangibles fell 12.36% to $52.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $52.6 billion through Dec 2025, down 12.36% year-over-year, with the annual reading at $52.6 billion for FY2025, 12.36% down from the prior year.
  • Intangibles for Q4 2025 was $52.6 billion at AbbVie, up from $711.0 million in the prior quarter.
  • The five-year high for Intangibles was $81.3 billion in Q1 2021, with the low at $711.0 million in Q3 2025.
  • Average Intangibles over 5 years is $62.8 billion, with a median of $63.9 billion recorded in 2023.
  • The sharpest move saw Intangibles skyrocketed 346.59% in 2021, then plummeted 98.93% in 2025.
  • Over 5 years, Intangibles stood at $76.0 billion in 2021, then fell by 11.21% to $67.4 billion in 2022, then fell by 17.54% to $55.6 billion in 2023, then rose by 8.02% to $60.1 billion in 2024, then decreased by 12.36% to $52.6 billion in 2025.
  • According to Business Quant data, Intangibles over the past three periods came in at $52.6 billion, $711.0 million, and $57.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.